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Wheat germ agglutinin has been conjugated to the surfaces of sonicated phospholipid liposomes by reacting the protein 
derivatised with N-succinimidyl-Sacetylthioacetate (SATA) with the m-maleimidobenzoyl-Nhydroxysuccinimide (MBS) 
derivative of dipalmitoylphosphatidylethanolamine (DPPE) incorporated into the liposomal bilayers. The liposomes as 
characterised by photon correlation spectroscopy had a weight-average radius of 44 k 10 nm and the number of WGA 
molecules per liposome was in the range up to approx. 120. An ELISA method has been developed to assess the efficiency 
of targeting the conjugated liposomes to the antigenic determinants on a surface coated with glycophorin A (blood group 
B). For liposomes in which the degree of conjugation was controlled by varying the molqb DPPE-MBS from 3 to 27% 
targeting efficiency as assessed from the extent of inhibition of the ELISA increased by a factor of 10. 
Lectin; Liposome; Targeting; ELISA 
1. INTRODUCTION 
The widespread interest in the use of liposomes 
as carriers of drugs, vaccines and other therapeutic 
agents [l-3] has led to studies directed to methods 
of incorporating glycoproteins [4-71 into liposome 
bilayers or covalently coupling proteins, par- 
ticularly antibodies, to liposomal surfaces [S-lo]. 
The objective of many of these studies was to im- 
prove the affinity of the liposomes for specific 
target sites on biosurfaces by exploiting bio- 
chemical specificity. 
The binding specificities of lectins for sugars 
[l l] make them an interesting alternative for 
targeting liposomes to the glycocalyx of membrane 
surfaces and other biosurfaces and lectins have 
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been used as mediators in the targeting of lipo- 
somes to erythrocytes by either physically coating 
the erythrocytes with lectin [12] or by physically 
coating the liposomes [13]. Although there is no 
substitute for the in vivo assessment of targeting 
efficiency it is nevertheless desirable to have an in 
vitro system of assaying the effectiveness of 
targeting of liposomes bearing site-directed surface 
groups. When assessing parameters which affect 
targeting it is important to target to a reproducible 
model surface. 
Here, sonicated liposomes incorporating phos- 
phatidylethanolamine activated with m-male- 
imidobenzoyl-N-hydroxysuccinimide have been 
coupled with the N-succinimidyl-S-acetylthio- 
acetate (SATA) derivative of wheat germ ag- 
glutinin (WGA). The efficiency of targeting of the 
resulting proteoliposomes to a glycophorin A sur- 
face has been investigated using a newly developed 
competitive enzyme-linked immunosorbent assay 
(ELISA). 
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2. EXPERIMENTAL 
2.1. Materials 
L-cu-Dipalmitoylphosphatidylethanolamine (DPPE, product 
no. P-0890), L-a-dipalmitoylphosphatidylcholine (DPPC, 
product no. P-0763), WGA (from Triticum vulgaris, product 
no. L-9640), glycophorin (from human blood type B, product 
no. G9511) and Sigma 104 phosphatase substrate tablets were 
obtained from Sigma (Poole, Dorset, England). SATA was 
from Calbiochem (Cambridge, England). m- 
Maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) was 
from Pierce Warriner (Chester, England). Phosphatidylinositol 
(PI) grade I was from Lipid Products (South Nutfield, Surrey, 
England). Anti-B (mouse hybridoma) was from Chembiomed 
(Edmonton, Canada) and alkaline phosphatase conjugate goat 
anti-mouse IgM antibody b chain specific) was from Tago 
Immunodiagnostics (Burlingame, CA). [‘H)DPPC was from 
Amersham International. 
2.2. Methods 
2.2.1. Derivatisation of WGA with SATA [14] 
The SATA derivative of WGA was prepared by addition of 
SATA (0.69-6.9amol in 50~1 dimethylformamide) to WGA 
[0.28 pmol in 2.5 ml phosphate (50 mM)-EDTA (1 mM) buf- 
fer, pH 7.51 at room temperature. The solution always con- 
tained less than 10 pl dimethylformamide/ml. The reaction was 
complete in 15 min after which derivatized WGA was separated 
from unreacted SATA by gel filtration on a Sephadex G-50 col- 
umn (15 x 2 cm). Fractions (2 ml) were collected and the WGA 
fractions (detected at AZSO .,) were pooled and stored at 4°C. 
The extent of derivatisation of the WGA was determined after 
deacetylation of the sulphydryl group of the SATA by reaction 
with a solution of hydroxylamine (0.5 M plus 25 mM EDTA 
and solid NazHP04 to pH 7.5). The sulphydryl content of the 
deprotected WGA derivative was determined using 5,5’-dithio- 
bis(2-nitrobenzoic acid) (DTNB) as described by Ellman 1151. 
Protein was assayed according to Lowry et al. [16] using a 
WGA (O-200 pg/lOO ~1) standard. 
2.2.2. Synthesis of the MBS derivative of DPPE 
DPPE (40 mg) was dissolved in a mixture of dry chloroform 
(16 ml), dry methanol (2 ml) and dry triethylamine (20 mg). 
MBS (20 mg) was added and the reaction mixture was stirred 
under nitrogen at room temperature for 24 h, after which the 
organic phase was washed three times with phosphate-buffered 
saline (PBS, pH 7.3) to remove unreacted MBS. The DPPE- 
MBS derivative was recovered from the organic phase by rotary 
evaporation and analysed by TLC using a silica plate and a sol- 
vent mixture containing chloroform, methanol and glacial 
acetic acid (65 : 25 : 13, by vol.). TLC confirmed that there was 
negligible contamination of DPPE-MBS (Rr 0.78) with DPPE 
(Rf 0.56). The DPPE-MBS was stored in a chloroform- 
methanol (9: 1, v/v) mixture at 4°C. 
2.2.3. Vesicle preparation and conjugation 
DPPC (9 mg), PI (1 mg) and variable amounts of DPPE- 
MBS (0.4-4.5 mg) plus lOOa [3H]DPPC (4pCi/ml) were 
dissolved in chloroform (20 ml) and methanol (5 ml) in a 1 1 
round-bottomed flask. The mixture was rotary evaporated at 
60°C to yield a thin lipid film. The lipid film was dispersed in 
5 ml nitrogen-saturated PBS at 6O”C, vigorously shaken and 
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transferred to a glass test-tube, purged with nitrogen, sealed 
with a suba-seal and sonicated in a bath sonicator (Decon 
FSlOO) at 60°C until visibly clear (1 h). The initial diameters of 
the vesicles were measured by photon correlation spectroscopy 
(PCS) using a Malvern autosizer. The liposome suspension was 
then applied to a Sephadex G-200 column (30 x 2 cm) previous- 
ly equilibrated with PBS (pH 7.3) at a flow rate of 0.2 ml/min. 
Fractions (2 ml) were collected and aliquots (100 ~1) of the frac- 
tions taken for scintillation counting. The size of the liposomes 
in the peak fraction was also measured by PCS. 
The liposome fractions containing the highest [3H]DPPC 
counts were mixed with derivatized WGA in appropriate pro- 
portions and reacted overnight at 4°C after which vesicle size 
was again monitored. The reaction mixture was applied to the 
Sephadex G-200 column and fractions (2 ml) collected. The 
fractions were assayed for protein content [14] and lipid from 
the [jH]DPPC count. 
2.2.5. Targeting assay 
The targeting of the WGA-conjugated liposomes to a model 
biosurface (glycophorin A from blood group B) was assessed by 
ELISA. The microtitre plate (Dynatech M129B) wells were in- 
cubated with 100 pl glycophorin solution (0.02 g/l in PBS) for 
12 h at 4°C or 2 h at 37°C. After washing (3 x 300~1 PBS), 
blocking of non-specific sites [300 81 of 1% bovine serum 
albumin (BSA) in PBS for 30 min at 37°C followed by 0.1% 
BSA/PBS] various amounts of liposomes were added in 100 pl 
of 0.1% BSA/PBS for 2 h at 37”C, after which the plates were 
washed with 0.1% BSA/PBS. Antibody-antibody conjugate 
(1OOgl) mixture (100 pl anti-B mouse hybridoma plus 10~1 
alkaline phosphatase goat anti-mouse IgM conjugate in 4.89 ml 
of 0.1% BSA/PBS premixed for 30 min) was added and in- 
cubated for 2 h at 37°C. After incubation the plate was washed 
with PBS (2 x 300 al) and then water (4 x) and 100 gl substrate 
[5 mg p-nitrophenylphosphate disodium hexahydrate in 5 ml 
glycine buffer (0.1 M glycine plus 2 mM MgC12 and 1 mM 
ZnClZ, pH 10.4)] added. The plate was left in the dark for 
30 min and the absorbances measured at 405 nm. The washing 
steps were performed using a Dynatech 96-channel automatic 
washer (AM56) and the plates were read using a Dynatech 
MR610 reader coupled to an Apple IIe microcomputer. 
3. RESULTS AND DISCUSSION 
The results of derivatisation of WGA 
are shown in fig.1 which illustrates 
number of SATA residues which can 
porated into WGA by the method 
reaches a limiting value of approx. 3 per 
by SATA 
that the 
be incor- 
described 
molecule. 
The number of lysine plus N-terminal residues in 
the WGA dimer is 14-16 [17,18]. The extent of 
derivatisation of WGA is comparable to that 
found for other proteins using SATA [14]. In this 
work the M, of dimeric WGA was taken to be 
36 000 117,191. Routinely, a reaction mole ratio of 
10: 1 SATA to WGA was used, giving approx. 2 
reactive sulphydryl groups per dimeric WGA. 
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Fig.1. The derivatisation of wheat germ agglutinin (WGA) by 
SATA. 
Fig.2 shows the gel filtration profile after con- 
jugation in a typical liposome preparation. After 
sonication the unconjugated liposomes eluted in 
the void volume on a G-200 column; after reaction 
with derivatised WGA the unreacted WGA gave a 
peak clearly separated from the WGA-conjugated 
liposomes with a Kd of 0.64. 
Fig.3 shows the results of an ELISA assay in 
which liposomes conjugated with WGA were 
targeted to glycophorin with blood group B anti- 
genie determinants and their effectiveness in block- 
ing access to B-antibodies, as a result of 
liposome-bound WGA binding to sugar (preferen- 
tially N-acetylglucosamine) residues was assayed. 
It is seen that in contrast to ‘naked’ liposomes, 
liposomes conjugated with WGA effectively in- 
hibit the assay for B group activity. In this exam- 
ple, inhibition was -83% when the glycophorin 
layer had been exposed to 0.4 mM liposomal lipid. 
The extent of conjugation was approx. 40,~g 
WGA/pmol lipid so that the concentration of con- 
jugated WGA was approx. 1 ,uM. It is significant 
that free WGA at this and higher (up to 4 ,KM) con- 
centrations did not inhibit the assay. Some inhibi- 
tion by free WGA might be expected, however it is 
possible that in contrast to liposomal WGA, free 
WGA is more easily removed in the wash steps 
which proceed antibody-antibody-conjugate addi- 
tion either as free WGA or possibly as partially 
complexed glycophorin, alternatively it is possible 
that inhibition requires multivalent binding which 
may occur more readily with liposomal WGA. 
The relationship between targeting efficiency 
(ability to inhibit the ELISA assay) and the degree 
of coupling of WGA to the liposomes was in- 
vestigated in a series of experiments in which the 
amount of DPPE-MBS in the liposomes was 
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Fig.2. The elution profile of WGA-conjugated liposomes and 
unreacted WGA on a Sephadex G-200 column. Left-hand or- 
dinate, activity of [‘HIDPPC (0); right-hand ordinate, WGA 
concentration (0). The conjugated liposomes elute in the void 
volume of the column. The fraction volume was 2 ml. 
varied. Fig.4 shows targeting efficiency for lipo- 
somes in which the mole percentage of DPPE- 
MBS was varied from 3 to 27%. We found that 
when the amount of DPPE-MBS exceeded 27% 
the liposomes readily agglutinated and uncoupled 
WGA could not be satisfactorily separated by gel 
filtration. In the range up to 27 mol% DPPE-MBS 
the extent of WGA coupling increased monotoni- 
cally up to 50 pg WGA/pmol lipid (i.e. 1.4 mmol 
WGA/mol lipid). The efficiency of targeting in- 
creases with the degree of coupling. As follows 
2oL 
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Fig.3. Competitive inhibition of the ELISA of glycophorin A 
(blood group B) antigenic determinants by WGA-conjugated 
liposomes (0). Control, unconjugated liposomes (0). WGA 
was conjugated to liposomes incorporating 10 mol% DPPE- 
MBS to give approx. 4Opg WGA/pmol lipid. 
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Fig.4. The effect of the degree of conjugation of WGA in 
WGA-conjugated liposomes on the competitive inhibition of 
the ELISA of glycophorin A (blood group B) antigenic deter- 
minants. The degree of conjugation was controlled by the 
mol% of DPPE-MBS in the liposomes which were as follows; 
0, 3%; n , 5%; 0, 10%; 0, 15%; A, 27%. 
from fig.4 for WGA-conjugated liposomes at a 
lipid concentration of 0.2 mM (0.2 pmol/lOO ,J in 
the microtitre well) inhibition increases by a factor 
of approx. 10 between liposomes conjugated with 
3 and 27% DPPE-MBS. 
The liposomes were characterised by photon 
correlation spectroscopy during each stage of their 
preparation. In the series of experiments shown in 
fig.4 the weight-average radii (rw) of the initial 
sonicated liposomes was 36 f 4 nm; after gel 
filtration on Sephadex G-200 the peak fractions 
taken for conjugation had an r, of 35 f 5 nm. 
After conjugation the size increased to 40 + 6 nm 
and the peak fractions after separation of un- 
reacted WGA by gel filtration on G-200 had an r, 
of 44 f 10 nm. Taking an area per lipid molecule 
of 0.5 nm’ and a bilayer thickness of 7.5 nm [20] 
the number of WGA molecules per liposome based 
on the weight-average radii range from 17 (3% 
DPPE-MBS) to 117 (27% DPPE-MBS). 
These experiments demonstrate that liposome 
targeting can be very rapidly and conveniently 
assessed using competitive inhibition of an ELISA 
system and that targeting with lectins is convenient 
and effective for carbohydrate antigenic deter- 
minants. The method described should be capable 
of adaptation and development to assess the effi- 
ciency of liposome targeting to many cellular an- 
tigens which can be immobilised. 
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